Integrating Molecular Approaches to Surveil Rejection: %dd-cfDNA, DSA, and Molecular (MMDx) Biopsy Assessment
Date/Time: Thursday, September 30, 2021 - 12:15 PM to 2:05 PM EDT
MMDx at 2021 ASHI Hybrid Annual Meeting
21 September 2021
Please join us for the 2021 ASHI Hybrid Annual Meeting where Dr. Halloran will be presenting "DSA-negative HLA antibody-negative molecular ABMR releases donor-derived cell-free DNA in the Trifecta study." Abstract details can be found here.
MMDx will be featured in Natera Inc.'s Symposium on September 30th from 12:15 pm to 2:05 pm EDT. Registration details can be found here.